Schweizer Claudia, Strnad Vratislav
Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany.
Clin Transl Radiat Oncol. 2025 Feb 25;52:100938. doi: 10.1016/j.ctro.2025.100938. eCollection 2025 May.
We thank the colleagues Topkan and the co-authors for their valuable comments on our study. As they stated correctly, there for sure are more factors influencing the development of necrosis - nicotine and alcohol might also play an important role, for example. Also some hints point at the distance of the catheters being associated with risk of necrosis. Due to the fact that the risk factors influence each other in their effect on the risk of necrosis and usually have an additive effect and due to the generally retrospective data collections in published articles on interventional radiotherapy in the oral cavity, some risk factors for late side effects cannot be perfectly recorded and evaluated. In our understanding, not only the distance to the mandible, but also the bone volume which is affected by radiation dose must be considered. No specific dose constraints exist for the mandible when applying interventional radiotherapy. We are currently analyzing further dose parameters available within CT-based planning workflows and hope for more detailed information on how we can improve the implants. Nevertheless, prospective data is needed to sufficiently address toxicity issues in a larger cohort of patients with long-term follow-up. As far as the disease-free survival is concerned, we indeed estimated this according to the current practice in several other published data without taking the event of death into account. This is obvious when looking at our results. Still, we agree that the different ways of presenting freedom of recurrence throughout the literature makes comparison rather difficult and should be unified. We thank you for your remark and will consider this in our future work.
我们感谢托普坎同事及其共同作者对我们研究提出的宝贵意见。正如他们正确指出的,肯定有更多因素影响坏死的发生——例如,尼古丁和酒精可能也起着重要作用。也有一些线索表明导管的距离与坏死风险相关。由于风险因素在对坏死风险的影响中相互作用,且通常具有累加效应,还由于已发表的口腔介入放疗文章中普遍采用回顾性数据收集方式,一些晚期副作用的风险因素无法得到完美记录和评估。在我们看来,不仅要考虑到与下颌骨的距离,还必须考虑受辐射剂量影响的骨体积。在进行介入放疗时,对于下颌骨不存在特定的剂量限制。我们目前正在分析基于CT的治疗计划流程中可用的进一步剂量参数,并希望能获得更多关于如何改进植入物的详细信息。然而,需要前瞻性数据来在更大规模的长期随访患者队列中充分解决毒性问题。就无病生存期而言,我们确实是根据其他一些已发表数据中的现行做法进行估算的,未考虑死亡事件。从我们的结果中可以明显看出这一点。尽管如此,我们同意,文献中呈现复发自由度的不同方式使得比较相当困难,应该加以统一。感谢您的评论,我们将在未来的工作中予以考虑。